Teva’s ProAir Digihaler FDA Approved to Monitor Asthma and COPD Treatment

The ProAir Digihaler monitors how it's used and uploads the data to an accompanying smartphone app via Bluetooth wireless connectivity. Specifically, the device detects every time it has been use to administer treatment, as well as the inspiratory airflow during each inhalation. "There are 25 million Americans living with asthma, many of whom use inhalers as part of their treatment regimen. Despite advancements in care over the years, we know that many are using their rescue medications in...

from A via a.sfakia on Inoreader http://bit.ly/2RG9hju